Trevena Announces TRV027 Selected by NIH-Funded ACTIV Initiative For COVID-19 Trial

NEXT STORY
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
PREV STORY
Trevena Reports First Quarter 2021 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Invuity to Present at Piper Jaffray Healthcare Conference

SAN FRANCISCO, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical ...

author_avatar
NASDAQ Market News

CORRECTING and REPLACING – Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)

Salix Sales Force to Promote First FDA-Approved Drug for Thrombocytopenia in Chronic Liver Disease ...

author_avatar
NASDAQ Market News

World Salt Awareness Week

Naples, FL, March 05, 2018 (GLOBE NEWSWIRE) -- World Salt Awareness Week is being ...

author_avatar
NASDAQ Market News